Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2026-01-14 @ 8:53 PM
Study NCT ID:
NCT02854618
Status:
UNKNOWN
Last Update Posted:
2021-02-01
First Post:
2016-08-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immune Response for Patients With Metastatic Breast Cancer Treated by Everolimus
Sponsor:
Centre Hospitalier Universitaire de Besancon
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-26
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-05
Completion Date Type:
ESTIMATED
First Submit Date:
2016-08-01
First Submit QC Date:
None
Study First Post Date:
2016-08-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-29
Last Update Post Date:
2021-02-01
Last Update Post Date Type:
ACTUAL